Laboratory of Cellular and Molecular Physiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Laboratory of Cellular, Genetic, and Molecular Nephrology, Renal Division, University of São Paulo, São Paulo, Brazil.
Sci Rep. 2019 Dec 20;9(1):19604. doi: 10.1038/s41598-019-55284-7.
Podocytes are specialized cells with a limited capacity for cell division that do not regenerate in response to injury and loss. Insults that compromise the integrity of podocytes promote proteinuria and progressive renal disease. The aim of this study was to evaluate the potential renoprotective and regenerative effects of mesenchymal stromal cells (mSC) in a severe form of the podocyte injury model induced by intraperitoneal administration of puromycin, aggravated by unilateral nephrectomy. Bone derived mSC were isolated and characterized according to flow cytometry analyses and to their capacity to differentiate into mesenchymal lineages. Wistar rats were divided into three groups: Control, PAN, and PAN+ mSC, consisting of PAN rats treated with 2 × 10 mSC. PAN rats developed heavy proteinuria, hypertension, glomerulosclerosis and significant effacement of the foot process. After 60 days, PAN rats treated with mSC presented a significant amelioration of all these abnormalities. In addition, mSC treatment recovered WT1 expression, improved nephrin, podocin, synaptopodin, podocalyxin, and VEGF expression, and downregulated proinflammatory Th1 cytokines in the kidney with a shift towards regulatory Th2 cytokines. In conclusion, mSC administration induced protection of podocytes in this experimental PAN model, providing new perspectives for the treatment of renal diseases associated with podocyte damage.
足细胞是具有有限分裂能力的特化细胞,在受到损伤和丢失时不会再生。损害足细胞完整性的因素会导致蛋白尿和进行性肾病。本研究的目的是评估间充质基质细胞(mSC)在腹腔注射嘌呤霉素诱导的严重足细胞损伤模型中的潜在肾保护和再生作用,该模型通过单侧肾切除加重。根据流式细胞术分析和向间充质谱系分化的能力,分离和表征了来源于骨的 mSC。Wistar 大鼠分为三组:对照组、PAN 组和 PAN+mSC 组,PAN 组大鼠接受 2×10 mSC 治疗。PAN 大鼠出现大量蛋白尿、高血压、肾小球硬化和足突明显消失。60 天后,mSC 治疗的 PAN 大鼠的所有这些异常均显著改善。此外,mSC 治疗恢复了 WT1 的表达,改善了肾小球裂孔膜蛋白、足突蛋白、突触蛋白、足细胞蛋白和 VEGF 的表达,并下调了肾脏中的促炎 Th1 细胞因子,向调节性 Th2 细胞因子转变。总之,mSC 给药在这种实验性 PAN 模型中诱导了足细胞的保护,为治疗与足细胞损伤相关的肾脏疾病提供了新的视角。